Mapping the English and Chinese versions of the Functional Assessment of Cancer Therapy-General to the EQ-5D utility index.
暂无分享,去创建一个
Fei Gao | Julian Thumboo | Y. Cheung | J. Thumboo | Yin-Bun Cheung | J. Wee | C. Goh | Gim-Yew Ng | Grace Pang | Wen-Hsin Koo | Vijay-Kumar Sethi | Joseph Wee | Cynthia Goh | G. Pang | W. Koo | V. Sethi | F. Gao | G. Ng
[1] N. Ikegami,et al. Estimating an EQ-5D population value set: the case of Japan. , 2002, Health economics.
[2] Vahram Ghushchyan,et al. Mapping the EQ-5D Index from the SF-12: US General Population Preferences in a Nationally Representative Sample , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.
[3] David Graddol,et al. The Future of Language , 2004, Science.
[4] M. Suarez‐Almazor,et al. Variation in the Estimation of Quality‐adjusted Life‐years by Different Preference‐based Instruments , 2003, Medical care.
[5] D. Jolliffe,et al. Censored least absolute deviations estimator: CLAD , 2001 .
[6] Y. Cheung,et al. The Singaporean English and Chinese versions of the EQ-5D achieved measurement equivalence in cancer patients. , 2009, Journal of clinical epidemiology.
[7] Nan Luo,et al. Do English and Chinese EQ-5D versions demonstrate measurement equivalence? an exploratory study , 2003, Health and quality of life outcomes.
[8] Y. Cheung,et al. The equivalence and difference between the English and Chinese versions of two major, cancer‐specific, health‐related quality‐of‐life questionnaires , 2004, Cancer.
[9] L. Sharples,et al. Performance status score: do patients and their oncologists agree? , 2003, British Journal of Cancer.
[10] D. Brennan,et al. Mapping oral health related quality of life to generic health state values , 2006, BMC Health Services Research.
[11] J. Thumboo,et al. Validity and reliability of the EQ-5D self-report questionnaire in Chinese-speaking patients with rheumatic diseases in Singapore. , 2003, Annals of the Academy of Medicine, Singapore.
[12] C. Goh,et al. Measuring quality of life in Chinese cancer patients: a new version of the Functional Living Index for Cancer (Chinese). , 2003, Annals of the Academy of Medicine, Singapore.
[13] P. Dolan,et al. Modeling valuations for EuroQol health states. , 1997, Medical care.
[14] N. Sengupta,et al. Mapping the SF-12 to the HUI3 and VAS in a Managed Care Population , 2004, Medical care.
[15] M. Farrell,et al. Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patients. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[16] Jacek A Kopec,et al. A comparative review of four preference-weighted measures of health-related quality of life. , 2003, Journal of clinical epidemiology.
[17] Y. Cheung,et al. Variability and sample size requirements of quality-of-life measures: a randomized study of three major questionnaires. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] D. Tulsky,et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] A Simon Pickard,et al. Estimation of patient preference-based utility weights from the functional assessment of cancer therapy - general. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[20] J. Thumboo,et al. Validity and reliability of the EQ-5D self-report questionnaire in English-speaking Asian patients with rheumatic diseases in Singapore , 2003, Quality of Life Research.
[21] William F Lawrence,et al. Predicting EuroQoL EQ-5D Preference Scores from the SF-12 Health Survey in a Nationally Representative Sample , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.